EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 14-Aug-2025 09:11 ET (14-Aug-2025 13:11 GMT/UTC)

A healthy diet in childhood is linked to starting menstrual periods later, regardless of BMI or height

European Society of Human Reproduction and Embryology
Peer-Reviewed Publication

Eating a healthy diet as a child is linked to girls having their first menstrual period at an older age than those who consumed a less healthy diet, according to a new study published in Human Reproduction. The findings remained unaltered by the girls’ body mass index or height, both of which have been associated with the earlier onset of periods. The study has implications for health in later life as it is well known that women who started their periods at an early age may be at higher risk for diabetes, obesity, breast cancer and diseases of the heart and blood vessels.

Journal: Human Reproduction
Funder: Breast Cancer Research Foundation, National Institutes of Health

NCCN Policy Summit builds bridges between primary care and oncology for better cancer outcomes

National Comprehensive Cancer Network
Meeting Announcement

The National Comprehensive Cancer Network(NCCN) hosted an Oncology Policy Summit in Washington, D.C. focused on improving care coordination between primary care and oncology providers.

SALSA: A new artificial intelligence tool for the automated and precise analysis of liver tumors

Vall d'Hebron Institute of Oncology
Peer-Reviewed Publication

Investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep learning-driven tool for the precise and completely automated detection and monitoring of liver tumors (hepatocellular carcinoma). Results of this work have been published as an open access article in Cell Reports Medicine.

Journal: Cell Reports Medicine

A novel approach to liver cancer treatment: Unlocking the therapeutic potential of ADH4-driven retinoic acid metabolism

Sichuan International Medical Exchange and Promotion Association
Peer-Reviewed Publication

A recent study published in Medcomm-Oncology highlights the pivotal role of the enzyme alcohol dehydrogenase 4 (ADH4) in suppressing hepatocellular carcinoma (HCC) progression. This inhibition is achieved through the facilitation of retinoic acid (RA) production and the disruption of Wnt/β-cantenin pathway. The researchers further demonstrated that the combination of RA with cisplatin markedly attenuates tumor growth in mouse models, presenting a promising therapeutic strategy for advanced HCC.

Journal: MedComm – Oncology

Personalized breast cancer prevention now available for women 30+ in the UK

Estonian Research Council
Reports and Proceedings

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast cancer and take early action years before NHS screening begins.

Diabetes drug as a possible treatment for prostate cancer

Medical University of Vienna
Peer-Reviewed Publication

An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPARγ, which is central to the regulation of metabolic processes, can also influence the growth of prostate cancer cells. PPARγ is already known to be a target of certain drugs used to treat type 2 diabetes. The results of the study, which have been published in the leading journal Molecular Cancer, indicate that such drugs could also represent a promising approach for the treatment of prostate cancer.

Journal: Molecular Cancer

HDAC11 deficiency improves muscle function and regeneration during ageing

Germans Trias i Pujol Research Institute
Peer-Reviewed Publication

Researchers from GRENBA-IGTP have identified the HDAC11 protein, an enzyme involved in cellular regulation, as a new therapeutic target to combat sarcopenia, the loss of muscle mass associated with ageing. The study shows that HDAC11 deficiency reduces muscle atrophy, preserves the muscle stem cell reservoir, promotes regeneration after injury and improves muscle function, opening the door to new strategies to support healthy ageing.

Journal: GeroScience

Electronic patient-reported outcome-based symptom management, a new era in surgical patient management

National Center for Respiratory Medicine
Peer-Reviewed Publication

Comment on: Dai W, Wang Y, Liao J, et al. Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial. J Clin Oncol 2024;42:2126-31.

Journal: Journal of Thoracic Disease

Neoadjuvant dual immuno-combination therapy with anti-LAG3 and anti-PD-1 antibodies is feasible and safe for resectable non-small cell lung cancer

National Center for Respiratory Medicine
Peer-Reviewed Publication

Comment on: Schuler M, Cuppens K, Plönes T, et al. Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial. Nat Med 2024;30:1602-11.

Journal: Journal of Thoracic Disease

The APPLE’s core question—upfront osimertinib versus the sequential approach for EGFR mutated non-small cell lung cancer

National Center for Respiratory Medicine
Peer-Reviewed Publication

Comment on: Remon J, Besse B, Aix SP, et al. Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer. J Clin Oncol 2024;42:1350-6.

Journal: Journal of Thoracic Disease